Revisiting liver transplant immunology: From the concept of immune engagement to the dualistic pathway paradigm

Liver Transplantation

Volumn 10, Issue 9, 2004, Pages 1081-1086

  Reding, Raymond ^a   Davies, Hugh F S ^b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; CALCINEURIN INHIBITOR; CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; METHYLPREDNISOLONE; RAPAMYCIN;

ALLOGRAFT; APOPTOSIS; CLINICAL PROTOCOL; CLONAL ANERGY; CYTOKINE PRODUCTION; EXPERIMENTAL MODEL; GRAFT REJECTION; HISTOCOMPATIBILITY; HOST; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; LIVER FAILURE; LIVER FUNCTION; LIVER GRAFT; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MAMMAL; MEDICAL RESEARCH; METHODOLOGY; MICROCHIMERISM; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REVIEW; RODENT; SPECIES DIFFERENCE; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ANIMALS; CHIMERISM; GRAFT REJECTION; HUMANS; LIVER TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 4544338168     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20171     Document Type: Review

References (24)

1. Riordan SM, Williams R. Tolerance after liver transplantation: does it exist and can immunosuppression be withdrawn? J Hepatol 1999;31:1106-1119.
2. Kamada N, Davies HffS, Roser B. Reversal of transplantation immunity by liver grafting. Nature 1981;292:840-842.
3. Qian S, Lu L, Fu F, Li Y, Li W, Starzl TE et al. Apoptosis within spontaneously accepted mouse liver allografts. Evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997;158:4654-4661.
4. Calne RY, Sells RA, Pena JR, Davis DR, Millard PR, Herbertson BM et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969;223:472-476.
5. Zimmermann FA, Davies HS, Knoll PP, Gokel JM, Schmidt T. Orthotopic liver allografts in the rat. The influence of strain combination on the fate of the graft. Transplantation 1984;37: 406-410.
6. Dousset B, Hubscher SG, Padbury RT, Gunson BK, Buckels JA, Mayer AD et al. Acute liver allograft rejection. Is treatment always necessary? Transplantation 1993;55:529-534.
7. Starzl TE, Marchioro TL, Waddell WR. The reversal of rejection in human renal homografts with subsequent development of homograft tolerance. Surg Gynecol Obstet 1963;117:385-395.
8. Kashiwagi N, Porter KA, Penn I, Brettschneider L, Starzl TE. Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg forum 1969;20:374-376.
9. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579-1582.
10. Strober S, Benike C, Krishnaswamy S, Engleman EG, Grumet FC. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Transplantation 2000;69:1549-1554.
11. Elwood ET, Larsen CP, Maurer DH, Routenberg KL, Neylan JF, Whelchel JD et al. Microchimerism and rejection in clinical transplantation. Lancet 1997;349:1358-1360.
12. Calne RY, Davies H. Organ graft tolerance: the liver effect. Lancet 1994;343:67-68.
13. Calne RY, Friend P, Moffatt S, Bradley A, Hale G, Firth J et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998; 351:1701-1702.
14. Rokahr KL, Sharland AF, Sun J, Wang C, Sheil AG, Yan Y et al. Paradoxical early immune activation during acceptance of liver allografts compared with rejection of skin grafts in a rat model of transplantation. Immunology 1998;95:257-263.
15. Bishop GA, Wang C, Sharland AF, McCaughan GW. Spontaneous acceptance of liver transplants in rodents: Evidence that liver leucocytes induce recipient T-cell death by neglect. Immunol Cell Biol 2002;80:93-100.
16. Bishop GA, McCaughan GW. Immune activation is required for the induction of liver allograft tolerance: Implications for immunosuppressive therapy. Liver Transpl 2001;7:161-172.
17. Sun J, McCaughan GW, Gallagher ND, Sheil AG, Bishop GA. Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 1995;60:233-236.
18. Wang C, Sun J, Sheil AG, McCaughan GW, Bishop GA. A short course of methylprednisolone immunosuppression inhibits both rejection and spontaneous acceptance of rat liver allografts. Transplantation 2001; 72:44-51.
19. Huan WH, Yan Y, De Boer B, Bishop GA, House AK. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts. Transplantation 2003;75: 368-374.
20. Salama AD, Remuzzi G, Harmon WE, Sayegh MH. Challenges to achieving clinical transplantation tolerance. J Clin Invest 2001;108:943-948.
21. Starzl TE, Murase N, Abu-Elmagd K, Gray EA, Shapiro R, Eghtesad B et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003;361:1502-1510.
22. Reding R, Gras J, Sokal E, Otte JB, Davies HFS. Steroid-free liver transplantation in children. Lancet 2003;362:2068-2070.
23. Starzl TE, Zinkernagel RM. Antigen localization and migration in immunity and tolerance. N Engl J Med 1998;339:1905-1913.
24. Schwartz RS. The new immunology. The end of immunosuppressive drug therapy? N Engl J Med 1999;340:1754-1756.